Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Hippo signaling pathway (mmu04390)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK019932
KLA  ATP  ATP+KLA
 AK019932 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330434N09 product:inferred: transmembrane receptor frizzled 5 {Mus musculus}, full insert sequence [AK019932] KLA .99 .94 .97 .98 .96 .99 1.03
ATP 1.02 1.07 1.02 .97 1.00 .98 .93
KLA/ATP .93 .99 .91 1.04 1.02 1.01 1.00
AK161134
KLA  ATP  ATP+KLA
 AK161134 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732464H19 product:unclassifiable, full insert sequence. [AK161134] KLA .94 1.00 .95 .99 1.03 .99 .88
ATP 1.08 1.07 1.21 1.02 1.05 .97 1.00
KLA/ATP .98 .94 1.02 .99 .91 1.05 .90
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Afp
KLA  ATP  ATP+KLA
 NM_007423 alpha fetoprotein (Afp), mRNA [NM_007423] KLA .86 .79 .70 .71 .49 .60 2.24
ATP .93 .84 1.36 1.15 1.01 1.65 2.49
KLA/ATP .76 .78 1.15 .87 .86 .80 2.07
Amh
KLA  ATP  ATP+KLA
 NM_007445 anti-Mullerian hormone (Amh), mRNA [NM_007445] KLA 1.02 .96 .94 1.02 1.03 .96 .97
ATP .95 1.06 1.00 1.21 .99 1.00 .98
KLA/ATP 1.01 .96 1.02 1.05 .94 .96 .97
Amot
KLA  ATP  ATP+KLA
 BC057638 angiomotin, mRNA (cDNA clone MGC:67773 IMAGE:2631191), complete cds. [BC057638] KLA 1.00 1.03 1.01 1.03 1.01 .97 .92
ATP 1.03 .96 .96 .99 1.01 .98 .99
KLA/ATP 1.00 .99 1.00 1.01 .97 1.05 .97
Amot
KLA  ATP  ATP+KLA
 NM_153319 angiomotin (Amot), mRNA [NM_153319] KLA .85 .85 .83 .80 .77 .70 .77
ATP 1.01 1.01 1.06 .87 .84 .82 .70
KLA/ATP .82 .79 .89 .79 .83 .77 .71
Apc
KLA  ATP  ATP+KLA
 NM_007462 adenomatosis polyposis coli (Apc), mRNA [NM_007462] KLA .98 .94 .91 .86 .83 .91 1.01
ATP 1.06 1.16 1.04 .97 1.63 1.50 1.25
KLA/ATP 1.01 1.01 .92 .88 1.22 1.46 1.21
Apc2
KLA  ATP  ATP+KLA
 NM_011789 adenomatosis polyposis coli 2 (Apc2), mRNA [NM_011789] KLA 1.05 1.15 1.12 1.13 1.07 1.11 1.08
ATP 1.04 .97 1.15 1.27 1.12 1.09 1.16
KLA/ATP 1.12 1.20 1.21 1.24 1.25 1.13 1.04
Areg
KLA  ATP  ATP+KLA
 NM_009704 amphiregulin (Areg), mRNA [NM_009704] KLA 1.06 1.06 1.04 1.18 1.02 .98 1.00
ATP 1.02 1.17 1.49 3.23 2.87 1.85 1.05
KLA/ATP 1.03 1.06 1.33 1.62 1.47 1.46 1.16
Axin1
KLA  ATP  ATP+KLA
 NM_009733 axin 1 (Axin1), mRNA [NM_009733] KLA .97 .91 1.14 1.08 1.23 1.21 1.07
ATP 1.08 1.06 .96 1.04 1.56 1.30 1.13
KLA/ATP 1.05 1.03 1.06 1.03 1.43 1.45 1.21
Axin2
KLA  ATP  ATP+KLA
 NM_015732 axin2 (Axin2), mRNA [NM_015732] KLA .91 .97 1.00 .97 1.00 .97 1.00
ATP .99 .97 .97 1.04 1.12 .98 1.01
KLA/ATP .98 .86 1.25 1.04 1.09 1.01 1.06
BB217526
KLA  ATP  ATP+KLA
 AK083592 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030051F04 product:unclassifiable, full insert sequence [AK083592] KLA 1.53 1.19 1.21 1.15 1.61 1.14 .87
ATP 1.33 1.11 1.15 1.11 2.06 1.48 1.13
KLA/ATP 1.36 1.18 1.61 1.37 1.77 1.10 1.13
BI646741
KLA  ATP  ATP+KLA
 BI646741 gb|BI646741 603279769F1 NCI_CGAP_Mam3 Mus musculus cDNA clone IMAGE:5320025 5, mRNA sequence [BI646741] KLA .55 .54 .47 .54 .65 1.09 1.60
ATP 1.04 .99 .93 1.08 2.49 .79 .88
KLA/ATP .54 .49 .54 .60 1.21 .97 1.54
Bbc3
KLA  ATP  ATP+KLA
 NM_133234 Bcl-2 binding component 3 (Bbc3), mRNA [NM_133234] KLA 1.53 1.37 1.05 1.26 .85 .64 .53
ATP .80 .68 .56 1.03 .64 .80 .35
KLA/ATP 1.40 1.09 .81 1.05 1.72 1.13 .54
Birc2
KLA  ATP  ATP+KLA
 NM_007465 baculoviral IAP repeat-containing 2 (Birc2), mRNA [NM_007465] KLA 4.63 4.59 3.77 2.79 2.32 2.07 1.84
ATP .95 .88 .84 .92 .76 1.34 1.28
KLA/ATP 4.70 4.93 4.13 2.60 1.34 1.60 2.31
Birc5
KLA  ATP  ATP+KLA
 NM_001012273 baculoviral IAP repeat-containing 5 (Birc5), transcript variant 3, mRNA [NM_001012273] KLA .41 .38 .29 .23 .13 .08 .06
ATP .95 .88 1.19 1.09 .67 .29 .05
KLA/ATP .38 .33 .41 .36 .27 .10 .04
Bmp2
KLA  ATP  ATP+KLA
 NM_007553 bone morphogenetic protein 2 (Bmp2), mRNA [NM_007553] KLA 1.18 1.19 1.30 1.16 1.02 1.07 .99
ATP 1.05 1.18 1.79 4.60 2.95 2.38 .96
KLA/ATP 1.26 1.52 1.77 2.64 1.78 1.47 .97
Bmp4
KLA  ATP  ATP+KLA
 NM_007554 bone morphogenetic protein 4 (Bmp4), mRNA [NM_007554] KLA 1.02 1.04 1.04 1.09 1.08 1.12 1.06
ATP .98 1.00 1.05 1.04 .94 .97 1.00
KLA/ATP .99 1.03 1.07 1.04 .99 .99 .97
Bmp5
KLA  ATP  ATP+KLA
 AK079078 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330158F20 product:unclassifiable, full insert sequence. [AK079078] KLA 1.04 1.02 1.02 1.01 .95 .94 1.05
ATP .98 .98 .99 .99 1.01 1.06 1.04
KLA/ATP .97 1.03 .98 .99 1.00 1.13 1.00
Bmp5
KLA  ATP  ATP+KLA
 NM_007555 bone morphogenetic protein 5 (Bmp5), mRNA [NM_007555] KLA .95 .99 1.00 1.02 1.04 1.07 1.07
ATP .97 1.07 .99 1.06 1.02 1.02 1.04
KLA/ATP 1.03 1.02 1.09 1.06 1.11 1.06 1.02
Bmp6
KLA  ATP  ATP+KLA
 NM_007556 bone morphogenetic protein 6 (Bmp6), mRNA [NM_007556] KLA 1.03 1.02 .97 .97 1.01 1.01 1.00
ATP .99 1.00 .96 .97 .94 .98 1.01
KLA/ATP .98 1.06 1.04 1.01 1.02 1.00 .98
Bmp7
KLA  ATP  ATP+KLA
 NM_007557 bone morphogenetic protein 7 (Bmp7), mRNA [NM_007557] KLA 1.00 .98 1.00 1.00 .99 1.00 1.00
ATP 1.00 .99 1.04 .97 1.01 1.01 1.01
KLA/ATP .98 .97 1.02 1.00 1.03 1.00 .99
Bmp8a
KLA  ATP  ATP+KLA
 NM_007558 bone morphogenetic protein 8a (Bmp8a), mRNA [NM_007558] KLA .95 .93 .96 1.03 1.00 .92 .98
ATP 1.07 .96 .97 1.50 1.90 1.94 1.64
KLA/ATP .98 .99 .98 1.24 1.43 1.49 1.37
Bmp8b
KLA  ATP  ATP+KLA
 NM_007559 bone morphogenetic protein 8b (Bmp8b), mRNA [NM_007559] KLA 1.12 1.03 1.05 1.06 1.07 1.05 1.04
ATP .97 1.03 1.04 .98 1.00 .94 1.04
KLA/ATP 1.06 1.05 .98 1.02 1.04 .95 1.07
Bmpr1a
KLA  ATP  ATP+KLA
 NM_009758 bone morphogenetic protein receptor, type 1A (Bmpr1a), mRNA [NM_009758] KLA .98 .98 .93 .89 .89 .92 1.00
ATP 1.03 .99 .98 .87 .97 1.08 1.03
KLA/ATP .99 1.00 .89 .85 .94 1.01 .92
Bmpr1b
KLA  ATP  ATP+KLA
 NM_007560 bone morphogenetic protein receptor, type 1B (Bmpr1b), mRNA [NM_007560] KLA .99 1.00 .93 .94 .98 .90 .94
ATP 1.11 1.06 .94 .95 .98 .88 .95
KLA/ATP .84 .92 .95 .90 .89 .90 .89
Bmpr2
KLA  ATP  ATP+KLA
 AK011534 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610024H22 product:unclassifiable, full insert sequence. [AK011534] KLA 1.17 1.10 1.17 1.35 1.31 1.08 .67
ATP 1.01 .89 .93 .55 .59 .82 .57
KLA/ATP 1.17 .99 1.12 .63 .74 .67 .50
Bmpr2
KLA  ATP  ATP+KLA
 AK140220 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230350M15 product:unclassifiable, full insert sequence [AK140220] KLA 1.21 1.16 1.17 1.25 1.42 .90 .98
ATP 1.20 1.22 .96 .97 .88 1.00 .76
KLA/ATP 1.20 1.36 .96 1.00 .84 .91 .94
Bmpr2
KLA  ATP  ATP+KLA
 NM_007561 bone morphogenic protein receptor, type II (serine/threonine kinase) (Bmpr2), mRNA [NM_007561] KLA 1.39 1.34 1.46 1.67 1.59 1.39 1.15
ATP .94 .95 1.10 .88 .91 1.24 1.31
KLA/ATP 1.33 1.36 1.39 1.13 1.15 1.34 2.01
Btrc
KLA  ATP  ATP+KLA
 NM_009771 beta-transducin repeat containing protein (Btrc), transcript variant 2, mRNA [NM_009771] KLA 1.30 1.33 1.62 1.50 1.93 1.79 1.60
ATP 1.07 1.30 1.05 1.26 .67 .99 1.56
KLA/ATP 1.40 1.61 1.13 1.72 .88 1.50 1.97
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Ccnd2
KLA  ATP  ATP+KLA
 NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53
ATP .98 .75 .50 .57 1.24 2.83 .40
KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57
Ccnd3
KLA  ATP  ATP+KLA
 NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45
ATP 1.05 1.14 .89 1.20 .74 .76 .99
KLA/ATP .70 .67 .54 .83 .61 1.19 1.45
Cdh1
KLA  ATP  ATP+KLA
 NM_009864 cadherin 1 (Cdh1), mRNA [NM_009864] KLA 1.03 1.03 .99 .94 .95 .97 .99
ATP 1.04 1.06 1.06 .96 .99 1.07 .95
KLA/ATP 1.02 1.07 1.00 .90 .93 .94 .98
Crb1
KLA  ATP  ATP+KLA
 AK044704 adult retina cDNA, RIKEN full-length enriched library, clone:A930034L24 product:hypothetical Aspartic acid and asparagine hydroxylation site/EGF-like domain, subtype 2/Laminin-G domain/EGF-like domain/Calcium-binding EGF-like domain conta KLA 1.01 1.02 .95 .95 .99 1.01 1.02
ATP .98 .97 1.01 1.01 .98 1.00 .93
KLA/ATP 1.00 .96 1.03 1.03 .98 .96 .99
Crb1
KLA  ATP  ATP+KLA
 AK044704 adult retina cDNA, RIKEN full-length enriched library, clone:A930034L24 product:hypothetical Aspartic acid and asparagine hydroxylation site/EGF-like domain, subtype 2/Laminin-G domain/EGF-like domain/Calcium-binding EGF-like domain contai KLA 1.09 1.03 .98 1.04 .99 1.06 1.05
ATP .99 1.02 1.07 1.02 .97 1.02 .98
KLA/ATP 1.04 .92 1.09 1.07 1.06 .97 1.11
Crb2
KLA  ATP  ATP+KLA
 BC043114 crumbs homolog 2 (Drosophila), mRNA (cDNA clone IMAGE:6413034), partial cds [BC043114] KLA .97 .92 1.05 1.04 1.07 1.02 1.05
ATP .98 1.05 .98 1.04 1.02 .99 .97
KLA/ATP 1.04 1.00 .96 1.01 1.06 1.06 .92
Csnk1d
KLA  ATP  ATP+KLA
 NM_027874 casein kinase 1, delta (Csnk1d), transcript variant 2, mRNA [NM_027874] KLA 1.18 1.24 1.40 1.51 1.46 1.33 1.20
ATP 1.03 .98 .90 .97 1.70 1.81 1.18
KLA/ATP 1.30 1.36 1.20 1.37 1.98 2.29 1.67
Csnk1d
KLA  ATP  ATP+KLA
 NM_139059 casein kinase 1, delta (Csnk1d), transcript variant 1, mRNA [NM_139059] KLA 1.72 1.90 2.07 2.00 2.02 1.88 1.60
ATP .94 1.05 1.01 1.34 2.03 2.97 1.70
KLA/ATP 1.77 1.86 1.85 2.18 2.27 2.99 3.01
Csnk1e
KLA  ATP  ATP+KLA
 NM_013767 casein kinase 1, epsilon (Csnk1e), mRNA [NM_013767] KLA .75 .69 .67 .71 .68 .64 .76
ATP .98 .89 .97 .94 1.80 .90 .83
KLA/ATP .68 .66 .70 .73 1.79 .84 .72
Ctgf
KLA  ATP  ATP+KLA
 NM_010217 connective tissue growth factor (Ctgf), mRNA [NM_010217] KLA 1.34 1.46 1.69 1.59 1.09 1.05 .84
ATP .94 .92 1.61 1.71 1.11 .87 1.16
KLA/ATP 1.14 1.50 2.63 3.09 2.41 1.14 1.08
Ctnna1
KLA  ATP  ATP+KLA
 AK008121 adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010005H04 product:unclassifiable, full insert sequence. [AK008121] KLA .82 .76 .72 .81 .94 .74 .80
ATP 1.08 1.01 .51 .57 2.45 1.25 .95
KLA/ATP .91 .82 .76 .58 1.58 1.01 .92
Ctnna1
KLA  ATP  ATP+KLA
 NM_009818 catenin (cadherin associated protein), alpha 1 (Ctnna1), mRNA [NM_009818] KLA .97 .91 1.06 .84 .75 .52 .56
ATP 1.09 1.14 1.00 .86 .80 .98 .83
KLA/ATP 1.02 1.07 .90 .80 .66 .59 .57
Ctnna2
KLA  ATP  ATP+KLA
 AK035033 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430076K22 product:hypothetical Vinculin and alpha-catenin containing protein, full insert sequence [AK035033] KLA 1.05 1.11 1.12 1.05 1.02 1.04 1.19
ATP .99 .97 1.00 1.05 1.02 1.05 1.03
KLA/ATP 1.11 1.06 1.01 1.12 1.06 1.02 1.03
Ctnna3
KLA  ATP  ATP+KLA
 AK029664 adult male testis cDNA, RIKEN full-length enriched library, clone:4930438F12 product:unclassifiable, full insert sequence. [AK029664] KLA 1.03 1.06 .99 1.05 .95 1.01 1.04
ATP 1.03 1.05 1.02 1.04 .99 1.03 1.05
KLA/ATP 1.01 1.00 .99 1.01 1.00 .98 1.05
Ctnna3
KLA  ATP  ATP+KLA
 NM_177612 catenin (cadherin associated protein), alpha 3 (Ctnna3), mRNA [NM_177612] KLA 1.01 1.06 .98 1.04 1.03 1.04 1.07
ATP .96 1.02 .94 1.11 1.02 1.09 .91
KLA/ATP 1.01 .94 .94 1.10 1.10 1.04 1.04
Ctnnb1
KLA  ATP  ATP+KLA
 AK020013 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830416C23 product:catenin beta, full insert sequence. [AK020013] KLA 1.06 1.15 1.00 1.06 1.27 1.14 1.03
ATP .85 .57 1.74 3.36 4.13 2.19 1.55
KLA/ATP 1.12 .87 2.47 3.61 3.79 2.21 2.06
Ctnnb1
KLA  ATP  ATP+KLA
 NM_007614 catenin (cadherin associated protein), beta 1 (Ctnnb1), mRNA [NM_007614] KLA 1.02 1.07 1.13 1.03 1.04 .93 .96
ATP 1.12 1.14 .75 .77 .73 .72 1.52
KLA/ATP 1.18 1.17 .77 .85 .60 .59 1.35
Dlg1
KLA  ATP  ATP+KLA
 AK031364 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030413K05 product:discs, large homolog 1 (Drosophila), full insert sequence. [AK031364] KLA .92 .85 .88 .82 .95 .91 .98
ATP 1.11 1.01 .90 .87 1.03 .93 .92
KLA/ATP .94 .93 .80 .81 1.01 .90 .87
Dlg1
KLA  ATP  ATP+KLA
 NM_007862 discs, large homolog 1 (Drosophila) (Dlg1), mRNA [NM_007862] KLA 1.17 1.11 1.13 1.05 .89 .91 1.05
ATP .98 .97 1.13 1.12 .90 .96 .91
KLA/ATP 1.24 1.11 1.14 1.02 .80 .83 .80
Dlg2
KLA  ATP  ATP+KLA
 NM_011807 discs, large homolog 2 (Drosophila) (Dlg2), mRNA [NM_011807] KLA .97 1.00 .96 1.01 .99 .94 1.00
ATP .99 1.02 1.04 1.02 .95 .92 1.06
KLA/ATP .89 1.00 1.02 .99 .95 .97 1.06
Dlg3
KLA  ATP  ATP+KLA
 NM_016747 discs, large homolog 3 (Drosophila) (Dlg3), mRNA [NM_016747] KLA .92 .99 1.10 1.41 1.34 1.07 .60
ATP .88 .80 .94 .66 .51 .56 .54
KLA/ATP .84 .90 .93 .58 .63 .75 .44
Dlg4
KLA  ATP  ATP+KLA
 NM_007864 discs, large homolog 4 (Drosophila) (Dlg4), transcript variant 1, mRNA [NM_007864] KLA .97 .97 .95 .93 .99 1.01 1.03
ATP .98 1.00 .95 .96 .93 .98 1.01
KLA/ATP .96 .97 .95 .93 .91 1.00 .93
Dvl1
KLA  ATP  ATP+KLA
 NM_010091 dishevelled, dsh homolog 1 (Drosophila) (Dvl1), mRNA [NM_010091] KLA .93 .91 .86 .74 .70 .80 1.05
ATP 1.01 1.01 .91 .91 .98 1.10 1.02
KLA/ATP 1.00 .93 .79 .82 .81 .85 1.06
Dvl2
KLA  ATP  ATP+KLA
 NM_007888 dishevelled 2, dsh homolog (Drosophila) (Dvl2), mRNA [NM_007888] KLA .49 .52 .48 .53 .52 .67 .75
ATP 1.08 1.08 .76 .93 1.47 .89 1.20
KLA/ATP .57 .47 .40 .61 1.37 .91 .92
Dvl3
KLA  ATP  ATP+KLA
 NM_007889 dishevelled 3, dsh homolog (Drosophila) (Dvl3), mRNA [NM_007889] KLA 1.08 1.09 1.05 1.18 1.11 1.10 1.11
ATP 1.00 1.01 1.05 1.05 .99 1.10 1.15
KLA/ATP 1.12 1.07 1.09 1.09 1.06 1.15 1.09
Fbxw11
KLA  ATP  ATP+KLA
 AK010033 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310065A07 product:unclassifiable, full insert sequence. [AK010033] KLA 1.30 1.21 1.27 1.21 1.47 1.01 1.13
ATP 1.19 2.03 1.28 .95 1.43 .99 1.04
KLA/ATP 1.43 1.83 1.40 1.10 1.12 1.05 1.05
Fbxw11
KLA  ATP  ATP+KLA
 NM_134015 F-box and WD-40 domain protein 11 (Fbxw11), mRNA [NM_134015] KLA 3.11 2.78 3.05 3.43 2.16 1.58 1.20
ATP 1.03 .94 1.72 1.19 1.38 1.66 1.01
KLA/ATP 2.76 2.70 4.18 2.07 1.91 2.02 1.71
Fgf1
KLA  ATP  ATP+KLA
 NM_010197 fibroblast growth factor 1 (Fgf1), mRNA [NM_010197] KLA 1.07 .99 .99 1.00 1.03 .97 .99
ATP 1.01 1.03 1.01 .95 .95 .98 .88
KLA/ATP 1.03 .99 .97 .99 .98 .94 1.01
Frmd6
KLA  ATP  ATP+KLA
 NM_028127 FERM domain containing 6 (Frmd6), mRNA [NM_028127] KLA .26 .26 .17 .18 .25 .24 .31
ATP 1.02 1.00 1.24 1.73 1.43 .94 1.10
KLA/ATP .29 .23 .28 .56 .72 .82 .58
Fzd1
KLA  ATP  ATP+KLA
 NM_021457 frizzled homolog 1 (Drosophila) (Fzd1), mRNA [NM_021457] KLA 15.53 16.47 14.36 11.40 6.80 2.73 2.49
ATP 1.01 1.02 1.39 2.05 6.43 10.47 1.41
KLA/ATP 12.71 14.30 14.99 14.06 9.72 9.90 8.10
Fzd10
KLA  ATP  ATP+KLA
 NM_175284 frizzled homolog 10 (Drosophila) (Fzd10), mRNA [NM_175284] KLA .99 .98 .99 1.03 1.03 1.02 .99
ATP .98 .98 .97 1.03 1.05 1.00 .96
KLA/ATP .96 .98 1.08 1.02 1.04 1.02 1.00
Fzd2
KLA  ATP  ATP+KLA
 NM_020510 frizzled homolog 2 (Drosophila) (Fzd2), mRNA [NM_020510] KLA .97 1.01 1.01 1.02 1.00 .96 .97
ATP 1.01 1.02 1.03 1.02 .97 1.03 .93
KLA/ATP 1.04 .98 .99 1.03 .99 1.03 .98
Fzd3
KLA  ATP  ATP+KLA
 NM_021458 frizzled homolog 3 (Drosophila) (Fzd3), mRNA [NM_021458] KLA 1.00 1.00 .99 1.04 1.02 1.06 1.07
ATP 1.00 1.00 .95 1.04 1.04 1.01 1.05
KLA/ATP .98 1.05 1.06 .99 1.02 1.00 1.03
Fzd4
KLA  ATP  ATP+KLA
 NM_008055 frizzled homolog 4 (Drosophila) (Fzd4), mRNA [NM_008055] KLA .96 .88 .91 .92 .82 .89 .84
ATP .97 .98 1.05 1.02 .93 .90 .96
KLA/ATP .82 .86 .97 .92 .88 .91 .92
Fzd5
KLA  ATP  ATP+KLA
 NM_022721 frizzled homolog 5 (Drosophila) (Fzd5), transcript variant 1, mRNA [NM_022721] KLA 1.63 1.69 1.56 1.23 .91 1.01 .92
ATP 1.03 1.32 4.46 9.23 7.72 2.14 1.11
KLA/ATP 1.63 1.92 4.20 8.67 8.29 3.07 1.12
Fzd6
KLA  ATP  ATP+KLA
 NM_008056 frizzled homolog 6 (Drosophila) (Fzd6), mRNA [NM_008056] KLA .97 1.01 .96 .90 .87 .94 .98
ATP .98 .97 .98 .94 .95 1.09 .96
KLA/ATP .97 1.02 .94 .92 .90 1.02 1.00
Fzd7
KLA  ATP  ATP+KLA
 NM_008057 frizzled homolog 7 (Drosophila) (Fzd7), mRNA [NM_008057] KLA 1.50 1.68 1.53 1.31 1.13 1.00 .94
ATP 1.04 1.12 1.60 3.45 2.56 1.72 1.02
KLA/ATP 1.89 1.92 1.96 4.61 3.75 3.38 1.88
Fzd8
KLA  ATP  ATP+KLA
 AK034561 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430006K02 product:inferred: transmembrane receptor {Mus musculus}; frizzled homolog 8 (Drosophila) homolog {GNF expression}, KLA 1.00 .98 1.05 .98 .96 1.03 .94
ATP 1.00 .92 1.06 1.05 1.02 1.01 .98
KLA/ATP .99 1.06 .99 .94 .95 .99 1.03
Fzd8
KLA  ATP  ATP+KLA
 NM_008058 frizzled homolog 8 (Drosophila) (Fzd8), mRNA [NM_008058] KLA 1.09 1.15 1.07 1.05 1.03 1.05 .98
ATP 1.05 1.08 2.01 3.38 2.89 1.20 1.03
KLA/ATP 1.04 1.17 1.65 2.57 2.62 1.40 1.04
Fzd9
KLA  ATP  ATP+KLA
 NM_010246 frizzled homolog 9 (Drosophila) (Fzd9), mRNA [NM_010246] KLA 1.03 1.10 1.12 .96 .98 1.00 .94
ATP 1.00 1.00 1.03 1.06 1.07 1.14 .98
KLA/ATP 1.10 1.07 1.03 .84 1.11 .96 .98
Gdf5
KLA  ATP  ATP+KLA
 NM_008109 growth differentiation factor 5 (Gdf5), mRNA [NM_008109] KLA 1.00 .93 .91 .99 1.06 1.04 1.16
ATP .99 .98 .97 .98 .89 .97 1.01
KLA/ATP .88 .96 1.01 .95 .89 .97 1.03
Gdf6
KLA  ATP  ATP+KLA
 NM_013526 growth differentiation factor 6 (Gdf6), mRNA [NM_013526] KLA .91 1.01 .99 1.02 .96 1.07 1.01
ATP .99 1.00 1.04 1.04 1.01 1.03 .98
KLA/ATP .98 .93 .98 .99 1.05 1.05 1.01
Gdf7
KLA  ATP  ATP+KLA
 NM_013527 growth differentiation factor 7 (Gdf7), mRNA [NM_013527] KLA .78 .75 .77 .90 .93 .92 .94
ATP .94 .95 1.01 .86 .92 .99 1.00
KLA/ATP .76 .73 .88 .82 .93 .86 .82
Gli2
KLA  ATP  ATP+KLA
 NM_001081125 GLI-Kruppel family member GLI2 (Gli2), mRNA [NM_001081125] KLA 1.03 1.02 .99 1.04 1.02 1.04 1.00
ATP 1.01 1.00 1.04 1.06 1.02 .99 1.04
KLA/ATP .97 1.04 1.05 1.05 1.06 1.04 1.02
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Id1
KLA  ATP  ATP+KLA
 NM_010495 inhibitor of DNA binding 1 (Id1), mRNA [NM_010495] KLA .72 .71 .65 1.22 .65 .61 .28
ATP .42 .19 .66 4.43 2.48 1.03 1.45
KLA/ATP .39 .23 .64 4.32 4.15 1.68 .89
Id2
KLA  ATP  ATP+KLA
 NM_010496 inhibitor of DNA binding 2 (Id2), mRNA [NM_010496] KLA .91 1.00 1.04 1.09 1.46 1.70 1.98
ATP 1.17 1.43 3.42 12.70 9.83 2.42 4.02
KLA/ATP 1.07 1.16 1.76 7.26 7.29 1.58 4.38
Id3
KLA  ATP  ATP+KLA
 NM_008321 inhibitor of DNA binding 3 (Id3), mRNA [NM_008321] KLA .67 .80 .84 1.69 1.16 .85 .53
ATP .87 .88 4.53 13.40 10.68 2.19 .74
KLA/ATP .79 .80 1.70 6.53 5.98 2.60 1.73
Id4
KLA  ATP  ATP+KLA
 NM_031166 inhibitor of DNA binding 4 (Id4), mRNA [NM_031166] KLA 1.01 1.03 .98 1.00 1.02 .97 1.00
ATP 1.00 1.00 1.00 1.04 1.01 .99 .97
KLA/ATP 1.01 1.00 .90 1.08 1.02 1.00 1.00
Inadl
KLA  ATP  ATP+KLA
 NM_001005784 InaD-like (Drosophila) (Inadl), transcript variant 2, mRNA [NM_001005784] KLA .98 .95 1.00 .96 1.02 .99 1.00
ATP 1.00 .99 .94 .94 1.05 1.17 1.12
KLA/ATP 1.00 .95 .97 1.07 1.00 1.01 1.09
Inadl
KLA  ATP  ATP+KLA
 NM_001005787 InaD-like (Drosophila) (Inadl), transcript variant 4, mRNA [NM_001005787] KLA .98 .93 1.01 .88 .96 .89 .94
ATP 1.07 .97 .99 .96 1.01 1.58 .96
KLA/ATP 1.05 1.04 1.09 1.02 .93 1.72 2.21
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Jub
KLA  ATP  ATP+KLA
 NM_010590 ajuba (Jub), mRNA [NM_010590] KLA .65 .58 .56 .66 .62 .65 .73
ATP .98 .96 .85 .70 .57 .68 .78
KLA/ATP .65 .58 .62 .66 .58 .56 .76
Lats1
KLA  ATP  ATP+KLA
 NM_010690 large tumor suppressor (Lats1), mRNA [NM_010690] KLA 2.08 1.73 1.97 1.72 1.81 1.61 1.53
ATP 1.24 1.26 1.09 .91 1.85 1.49 1.15
KLA/ATP 1.99 2.04 1.61 1.31 1.82 1.64 1.81
Lats2
KLA  ATP  ATP+KLA
 NM_015771 large tumor suppressor 2 (Lats2), mRNA [NM_015771] KLA .53 .50 .50 .58 .67 .85 .99
ATP 1.14 1.19 1.39 1.23 1.44 1.24 1.28
KLA/ATP .54 .52 .62 .65 1.22 1.16 1.20
Lef1
KLA  ATP  ATP+KLA
 NM_010703 lymphoid enhancer binding factor 1 (Lef1), mRNA [NM_010703] KLA 1.00 1.05 1.00 1.05 1.01 1.07 1.07
ATP .96 .98 1.03 1.09 .99 1.04 1.00
KLA/ATP 1.02 .98 .95 1.08 1.02 1.16 1.08
Limd1
KLA  ATP  ATP+KLA
 NM_013860 LIM domains containing 1 (Limd1), mRNA [NM_013860] KLA .81 .73 .71 .70 .67 .70 .92
ATP 1.07 1.10 1.00 .82 2.65 3.06 1.29
KLA/ATP .84 .81 .70 .64 1.15 1.61 1.22
Llgl1
KLA  ATP  ATP+KLA
 NM_008502 lethal giant larvae homolog 1 (Drosophila) (Llgl1), mRNA [NM_008502] KLA 1.38 1.33 1.49 1.35 1.13 1.21 1.09
ATP .97 1.01 .95 .85 .77 1.31 1.32
KLA/ATP 1.31 1.43 1.28 1.21 1.04 1.38 1.57
Llgl2
KLA  ATP  ATP+KLA
 NM_145438 lethal giant larvae homolog 2 (Drosophila) (Llgl2), mRNA [NM_145438] KLA .79 .70 .69 .79 .97 .98 1.19
ATP 1.06 1.13 .92 .90 1.16 1.79 1.33
KLA/ATP .84 .71 .73 .69 .81 1.58 1.39
Mm.21516
1
KLA  ATP  ATP+KLA
 141801906 Unknown KLA 1.08 1.09 1.10 1.08 1.09 1.05 1.12
ATP .95 .94 1.05 1.16 1.05 1.08 1.14
KLA/ATP 1.07 1.15 1.16 1.16 1.10 1.14 1.14
Mm.24600
3
KLA  ATP  ATP+KLA
 161086914 Unknown KLA 10.04 10.23 11.14 8.37 5.02 2.48 2.15
ATP .96 1.08 1.11 1.79 4.88 8.01 1.29
KLA/ATP 9.96 11.13 9.87 10.92 7.51 7.35 6.26
Mm.25703
5
KLA  ATP  ATP+KLA
 118136296 Unknown KLA 1.00 1.02 .97 .98 .99 1.06 .99
ATP .96 .96 1.01 1.05 .95 .99 1.00
KLA/ATP 1.01 1.03 .99 .98 .97 .99 1.04
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.28081
KLA  ATP  ATP+KLA
 118130427 Unknown KLA 1.04 .96 1.05 1.02 .97 .96 1.04
ATP .96 .91 1.00 .94 .92 .96 1.02
KLA/ATP .97 1.10 .97 .97 .93 .94 .91
Mm.2962
KLA  ATP  ATP+KLA
 34328509 Unknown KLA .19 .13 .08 .09 .14 .15 .21
ATP 1.00 .79 1.62 1.56 1.47 1.25 1.05
KLA/ATP .18 .12 .23 .43 .64 .86 .44
Mm.33565
9
KLA  ATP  ATP+KLA
 160333365 Unknown KLA 5.54 4.69 3.93 3.03 2.00 1.91 1.69
ATP .98 .81 1.01 .78 .68 1.71 1.10
KLA/ATP 5.05 4.44 5.07 2.38 1.34 1.88 2.00
Mm.45680
7
KLA  ATP  ATP+KLA
 157951728 Unknown KLA 1.00 1.02 1.05 .97 .99 .96 1.05
ATP 1.13 .98 1.00 1.06 1.02 .94 .98
KLA/ATP 1.11 .96 1.08 1.01 .99 1.01 .98
Mm.4744
KLA  ATP  ATP+KLA
 6679980 Unknown KLA 1.08 1.04 1.02 1.05 .98 1.02 .72
ATP 1.02 1.12 .98 1.06 1.02 1.00 1.00
KLA/ATP .96 1.00 1.11 1.04 .99 .97 1.01
Mm.4769
KLA  ATP  ATP+KLA
 31542830 Unknown KLA .93 .99 .86 .85 .75 .83 .80
ATP 1.01 1.00 .91 .83 .96 1.15 .84
KLA/ATP .95 .95 .92 .81 .85 1.12 .87
Mm.56964
KLA  ATP  ATP+KLA
 144227223 Unknown KLA .96 .99 1.00 .99 .97 1.01 1.05
ATP .99 .94 1.00 .94 .97 .99 .91
KLA/ATP 1.05 .97 1.02 .97 .91 1.00 1.02
Mm.71710
KLA  ATP  ATP+KLA
 158966712 Unknown KLA 1.23 1.26 1.52 1.32 1.46 1.45 1.38
ATP .98 1.07 1.18 1.51 1.49 1.15 1.18
KLA/ATP 1.27 1.45 1.29 1.61 1.65 1.41 1.54
Mobkl1a
KLA  ATP  ATP+KLA
 AK048590 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130082J22 product:unclassifiable, full insert sequence [AK048590] KLA 2.90 2.90 2.35 1.90 1.48 1.50 1.52
ATP .98 1.11 1.04 1.02 1.84 1.90 .74
KLA/ATP 2.84 2.85 2.01 1.94 2.15 1.47 1.11
Mobkl1a
KLA  ATP  ATP+KLA
 NM_026735 MOB1, Mps One Binder kinase activator-like 1A (yeast) (Mobkl1a), mRNA [NM_026735] KLA 2.21 2.41 2.47 2.49 2.49 2.26 2.02
ATP 1.03 1.08 1.29 1.47 1.54 2.95 2.66
KLA/ATP 2.32 2.33 2.28 2.67 2.20 2.71 4.16
Mobkl1b
KLA  ATP  ATP+KLA
 AK167515 11 days pregnant adult female placenta cDNA, RIKEN full-length enriched library, clone:I530018E08 product:Mob1 protein (Hypothetical protein) (Mob4B protein) homolog [Homo sapiens], full insert sequence [AK167515] KLA 1.67 1.76 1.94 1.73 1.86 1.31 1.34
ATP 1.16 1.27 .91 1.00 .98 .91 .95
KLA/ATP 1.77 1.87 1.08 1.37 .95 .83 .90
Mpp5
KLA  ATP  ATP+KLA
 BC075698 cDNA clone IMAGE:30640755, containing frame-shift errors [BC075698] KLA .93 .87 .79 .68 .81 .96 .97
ATP 1.01 1.08 .92 .93 3.29 2.21 1.39
KLA/ATP .94 .91 .76 .73 1.80 2.16 1.38
Mpp5
KLA  ATP  ATP+KLA
 NM_019579 membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) (Mpp5), mRNA [NM_019579] KLA .93 .90 .81 .78 .84 .93 .93
ATP 1.06 1.09 .97 1.09 3.90 2.42 1.49
KLA/ATP 1.04 .97 .86 .84 2.23 2.20 1.39
Myc
KLA  ATP  ATP+KLA
 NM_010849 myelocytomatosis oncogene (Myc), mRNA [NM_010849] KLA .38 .31 .45 .45 .49 .35 .33
ATP 1.05 1.09 1.72 4.41 1.28 .45 .76
KLA/ATP .37 .30 .44 1.23 .34 .17 .19
Nf2
KLA  ATP  ATP+KLA
 NM_010898 neurofibromatosis 2 (Nf2), mRNA [NM_010898] KLA 1.00 .99 1.03 .96 .92 .89 .97
ATP .90 .86 .83 .96 1.17 .85 .92
KLA/ATP .97 .90 .75 .79 .80 .90 .94
Nkd1
KLA  ATP  ATP+KLA
 AK076164 14, 17 days embryo head cDNA, RIKEN full-length enriched library, clone:3230401D10 product:naked cuticle 1 homolog (Drosophila), full insert sequence [AK076164] KLA .99 1.02 .98 1.09 .92 .98 .97
ATP .97 1.00 1.01 .89 .95 1.00 1.01
KLA/ATP 1.03 1.00 1.01 .97 .90 1.01 .94
Nkd1
KLA  ATP  ATP+KLA
 NM_027280 naked cuticle 1 homolog (Drosophila) (Nkd1), mRNA [NM_027280] KLA 1.01 1.01 .96 1.08 1.02 1.03 .94
ATP .95 1.09 1.00 .99 1.00 1.02 1.00
KLA/ATP .96 .95 .97 1.00 .96 .99 1.08
Pard3
KLA  ATP  ATP+KLA
 AK076429 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832405A21 product:par-3 (partitioning defective 3) homolog (C. elegans), full insert sequence. [AK076429] KLA .96 .96 1.03 .96 1.03 .99 1.19
ATP .97 .92 1.09 .99 1.00 1.03 .94
KLA/ATP .97 1.01 .97 1.05 .98 .92 1.04
Pard3
KLA  ATP  ATP+KLA
 NM_001013580 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 2, mRNA [NM_001013580] KLA 1.02 .99 1.03 .97 1.00 .97 1.04
ATP .93 1.02 .98 .95 1.02 1.02 .98
KLA/ATP 1.04 .98 1.01 .99 .96 .91 .95
Pard3
KLA  ATP  ATP+KLA
 NM_001013581 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 1, mRNA [NM_001013581] KLA .99 1.06 1.02 1.02 1.00 .98 .95
ATP .91 1.05 1.06 .99 1.04 .89 .99
KLA/ATP .98 .97 1.09 .97 1.01 .98 1.00
Pard3
KLA  ATP  ATP+KLA
 NM_001122850 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 4, mRNA [NM_001122850] KLA 1.01 .95 1.00 1.01 1.07 .91 .99
ATP 1.00 1.01 .98 .94 1.04 .98 1.00
KLA/ATP .99 .99 1.04 1.04 1.04 1.01 1.03
Pard3
KLA  ATP  ATP+KLA
 NM_033620 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 3, mRNA [NM_033620] KLA .92 .93 .97 .96 1.00 .99 1.02
ATP 1.08 1.03 .93 .92 .99 .97 1.00
KLA/ATP .99 1.03 1.02 1.05 .96 1.06 1.03
Pard6a
KLA  ATP  ATP+KLA
 NM_001047436 par-6 (partitioning defective 6,) homolog alpha (C. elegans) (Pard6a), transcript variant 3, mRNA [NM_001047436] KLA .85 .86 .99 1.14 1.22 1.22 1.02
ATP 1.17 1.16 1.11 1.14 .92 1.12 1.29
KLA/ATP .84 .88 1.14 1.20 1.22 1.32 1.26
Pard6b
KLA  ATP  ATP+KLA
 BC025147 par-6 (partitioning defective 6) homolog beta (C. elegans), mRNA (cDNA clone MGC:35871 IMAGE:2655658), complete cds [BC025147] KLA .97 .97 .91 .92 .92 .95 .97
ATP .97 .99 .99 .99 1.10 1.02 1.10
KLA/ATP .99 .97 .96 .95 1.10 1.11 1.13
Pard6b
KLA  ATP  ATP+KLA
 NM_021409 par-6 (partitioning defective 6) homolog beta (C. elegans) (Pard6b), mRNA [NM_021409] KLA .96 1.04 .96 1.03 .98 1.07 1.04
ATP 1.00 .92 1.02 1.01 .97 1.01 .98
KLA/ATP 1.02 .92 1.03 1.02 1.01 .97 1.01
Pard6g
KLA  ATP  ATP+KLA
 AK019835 adult male testis cDNA, RIKEN full-length enriched library, clone:4930590G08 product:unclassifiable, full insert sequence. [AK019835] KLA .95 .95 .84 .86 .78 .80 .76
ATP 1.01 .94 1.00 .88 .84 .89 .73
KLA/ATP .90 .87 .87 .81 .82 .73 .73
Pard6g
KLA  ATP  ATP+KLA
 NM_053117 par-6 partitioning defective 6 homolog gamma (C. elegans) (Pard6g), mRNA [NM_053117] KLA .92 .83 .73 .69 .56 .68 .57
ATP .98 .89 .92 .83 .69 .80 .56
KLA/ATP .86 .81 .72 .73 .66 .70 .53
Ppp1ca
KLA  ATP  ATP+KLA
 NM_031868 protein phosphatase 1, catalytic subunit, alpha isoform (Ppp1ca), mRNA [NM_031868] KLA .89 .93 .93 .86 .95 1.07 1.20
ATP 1.04 1.07 .93 1.02 1.01 .89 1.10
KLA/ATP .98 .93 .74 .91 .84 1.01 1.34
Ppp1cb
KLA  ATP  ATP+KLA
 NM_172707 protein phosphatase 1, catalytic subunit, beta isoform (Ppp1cb), mRNA [NM_172707] KLA 1.12 1.08 1.05 1.02 .89 .84 .94
ATP .89 .87 .75 .55 .73 1.14 .69
KLA/ATP .92 .94 .80 .64 .64 .83 .65
Ppp1cc
KLA  ATP  ATP+KLA
 NM_013636 protein phosphatase 1, catalytic subunit, gamma isoform (Ppp1cc), mRNA [NM_013636] KLA .51 .51 .49 .48 .53 .64 .64
ATP 1.02 1.01 .85 .79 .72 .89 .95
KLA/ATP .54 .49 .42 .43 .56 .76 .81
Ppp2ca
KLA  ATP  ATP+KLA
 NM_019411 protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform (Ppp2ca), mRNA [NM_019411] KLA 1.17 1.13 1.18 1.20 1.54 1.45 1.34
ATP 1.09 1.20 1.07 1.33 1.56 2.04 1.43
KLA/ATP 1.14 1.17 1.15 1.49 1.59 2.37 2.02
Ppp2cb
KLA  ATP  ATP+KLA
 NM_017374 protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (Ppp2cb), mRNA [NM_017374] KLA 1.32 1.33 1.37 1.24 1.27 1.09 1.18
ATP .94 .93 .82 .91 1.22 2.01 1.08
KLA/ATP 1.24 1.14 .80 .97 1.13 1.54 1.18
Ppp2r1a
KLA  ATP  ATP+KLA
 NM_016891 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform (Ppp2r1a), mRNA [NM_016891] KLA 1.44 1.39 1.47 1.37 1.69 1.33 1.16
ATP 1.18 1.55 .85 1.67 1.38 .99 1.24
KLA/ATP 1.66 1.98 .97 2.33 1.41 1.65 1.38
Ppp2r1b
KLA  ATP  ATP+KLA
 NM_001034085 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 1, mRNA [NM_001034085] KLA 1.26 1.17 1.14 1.13 1.12 1.11 .99
ATP .90 .90 .96 .98 1.59 1.71 1.16
KLA/ATP 1.23 1.16 .99 1.00 1.54 1.34 1.24
Ppp2r1b
KLA  ATP  ATP+KLA
 NM_028614 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 2, mRNA [NM_028614] KLA 2.38 2.38 2.53 1.80 1.52 .95 1.16
ATP 1.17 1.29 1.04 1.09 1.16 1.19 1.00
KLA/ATP 2.59 2.78 1.82 2.31 1.34 1.03 .75
Ppp2r2a
KLA  ATP  ATP+KLA
 NM_028032 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform (Ppp2r2a), mRNA [NM_028032] KLA 2.18 2.42 2.58 2.17 2.08 1.83 1.57
ATP 1.06 1.12 .90 1.28 1.76 1.70 1.39
KLA/ATP 2.55 2.38 1.62 2.68 2.25 2.55 1.86
Ppp2r2b
KLA  ATP  ATP+KLA
 AK086561 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930037C08 product:unclassifiable, full insert sequence [AK086561] KLA .94 1.02 1.07 1.02 1.02 .97 .98
ATP 1.01 1.04 1.01 .99 .97 .95 1.00
KLA/ATP 1.04 1.06 1.01 .96 1.02 .90 .93
Ppp2r2b
KLA  ATP  ATP+KLA
 NM_028392 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform (Ppp2r2b), transcript variant 2, mRNA [NM_028392] KLA 1.01 1.02 .96 1.00 1.04 1.01 1.00
ATP 1.00 .96 1.07 .93 .95 1.01 1.03
KLA/ATP .95 1.01 1.06 1.07 .98 1.02 1.03
Ppp2r2c
KLA  ATP  ATP+KLA
 NM_172994 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform (Ppp2r2c), mRNA [NM_172994] KLA .97 .98 .96 1.02 1.02 1.06 1.01
ATP .96 1.05 1.03 .98 1.01 1.04 1.06
KLA/ATP .98 .98 1.00 .96 1.00 .86 1.10
Ppp2r2d
KLA  ATP  ATP+KLA
 NM_026391 protein phosphatase 2, regulatory subunit B, delta isoform (Ppp2r2d), mRNA [NM_026391] KLA 1.07 1.03 1.14 1.18 1.16 1.27 1.13
ATP .96 .93 .95 .76 1.34 2.21 1.22
KLA/ATP 1.01 1.01 1.01 .87 1.91 2.19 2.18
Prkci
KLA  ATP  ATP+KLA
 NM_008857 protein kinase C, iota (Prkci), mRNA [NM_008857] KLA .92 .84 .75 .59 .50 .66 .90
ATP 1.06 1.20 1.15 1.10 1.14 1.04 1.00
KLA/ATP .83 .92 .75 .78 .99 1.06 .80
Prkcz
KLA  ATP  ATP+KLA
 NM_008860 protein kinase C, zeta (Prkcz), transcript variant 1, mRNA [NM_008860] KLA .92 .90 1.00 .99 1.07 1.05 1.12
ATP 1.01 .95 .94 .93 1.04 1.04 .95
KLA/ATP .95 .94 .95 .94 .99 1.02 .98
Rassf1
KLA  ATP  ATP+KLA
 NM_019713 Ras association (RalGDS/AF-6) domain family member 1 (Rassf1), mRNA [NM_019713] KLA .96 1.07 .99 1.34 1.55 2.00 1.74
ATP .94 .98 .99 1.14 1.94 2.54 2.03
KLA/ATP .99 1.16 1.01 1.28 2.98 2.91 4.25
Rassf6
KLA  ATP  ATP+KLA
 NM_028478 Ras association (RalGDS/AF-6) domain family member 6 (Rassf6), mRNA [NM_028478] KLA .96 .99 .95 .91 .91 1.03 1.08
ATP .97 .91 1.00 1.12 1.20 3.62 2.54
KLA/ATP .95 .98 .96 .85 .97 1.13 1.93
Sav1
KLA  ATP  ATP+KLA
 NM_022028 salvador homolog 1 (Drosophila) (Sav1), mRNA [NM_022028] KLA 5.16 5.05 4.96 4.22 2.91 2.17 1.81
ATP .98 1.00 1.07 .81 1.56 2.98 1.61
KLA/ATP 4.43 4.71 4.88 3.78 2.98 3.00 2.77
Scrib
KLA  ATP  ATP+KLA
 NM_134089 scribbled homolog (Drosophila) (Scrib), mRNA [NM_134089] KLA .59 .49 .43 .57 .50 .51 .58
ATP 1.08 .88 .86 .80 .83 .97 .71
KLA/ATP .51 .44 .49 .46 .58 .76 .67
Serpine1
KLA  ATP  ATP+KLA
 AK040662 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530009B11 product:serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1, full insert sequence. [AK040662] KLA 1.12 1.08 1.10 1.03 1.00 1.01 1.05
ATP 1.00 1.09 1.39 1.44 1.05 .95 .99
KLA/ATP 1.09 1.10 1.02 1.03 1.08 1.19 1.02
Serpine1
KLA  ATP  ATP+KLA
 NM_008871 serine (or cysteine) peptidase inhibitor, clade E, member 1 (Serpine1), mRNA [NM_008871] KLA 36.00 31.05 27.47 23.20 11.59 4.14 1.47
ATP .97 1.15 3.43 11.58 8.77 7.42 2.16
KLA/ATP 31.47 33.70 38.54 30.90 22.06 23.68 18.57
Smad1
KLA  ATP  ATP+KLA
 NM_008539 MAD homolog 1 (Drosophila) (Smad1), mRNA [NM_008539] KLA .54 .60 .74 .93 1.36 1.54 1.27
ATP .99 1.02 .81 .87 1.26 .93 .84
KLA/ATP .57 .55 .54 .63 1.04 .97 .88
Smad2
KLA  ATP  ATP+KLA
 NM_010754 MAD homolog 2 (Drosophila) (Smad2), mRNA [NM_010754] KLA 1.05 1.08 1.04 1.17 1.40 1.43 1.59
ATP 1.01 1.02 1.16 1.14 1.15 1.32 1.34
KLA/ATP 1.00 .99 .97 1.09 1.40 1.14 1.40
Smad3
KLA  ATP  ATP+KLA
 NM_016769 MAD homolog 3 (Drosophila) (Smad3), mRNA [NM_016769] KLA .64 .60 .57 .64 .70 1.25 1.52
ATP 1.02 1.02 .84 1.21 2.42 .90 1.19
KLA/ATP .64 .60 .65 .66 1.29 1.26 2.26
Smad4
KLA  ATP  ATP+KLA
 NM_008540 MAD homolog 4 (Drosophila) (Smad4), mRNA [NM_008540] KLA 1.11 1.11 1.13 1.09 1.02 .98 1.08
ATP 1.00 1.04 .92 .76 1.67 1.44 .92
KLA/ATP 1.09 1.01 .87 .89 1.64 1.43 .99
Smad7
KLA  ATP  ATP+KLA
 NM_001042660 MAD homolog 7 (Drosophila) (Smad7), mRNA [NM_001042660] KLA .58 .57 .41 .72 .72 1.04 .97
ATP 1.14 1.16 1.84 4.55 2.55 1.97 1.44
KLA/ATP .64 .58 .65 2.41 2.10 1.98 2.69
Snai2
KLA  ATP  ATP+KLA
 NM_011415 snail homolog 2 (Drosophila) (Snai2), mRNA [NM_011415] KLA 1.08 1.08 1.07 1.00 .98 1.00 1.11
ATP 1.02 .95 .96 1.04 .92 .99 .97
KLA/ATP 1.07 1.11 1.07 1.05 .93 1.07 .93
Sox2
KLA  ATP  ATP+KLA
 NM_011443 SRY-box containing gene 2 (Sox2), mRNA [NM_011443] KLA 1.06 .98 .92 1.00 .98 1.06 .92
ATP .99 1.08 1.00 .99 1.02 .99 1.06
KLA/ATP .98 1.04 .99 .99 1.02 1.05 1.05
Stk3
KLA  ATP  ATP+KLA
 AK021111 adult male corpus striatum cDNA, RIKEN full-length enriched library, clone:C030030N07 product:unclassifiable, full insert sequence. [AK021111] KLA .94 .92 1.00 .98 .97 .88 1.00
ATP .84 .91 .90 .83 .95 .94 .92
KLA/ATP .97 .92 .88 .86 .84 .85 .83
Stk3
KLA  ATP  ATP+KLA
 NM_019635 serine/threonine kinase 3 (Ste20, yeast homolog) (Stk3), mRNA [NM_019635] KLA 1.51 1.51 1.59 1.55 1.42 1.23 1.14
ATP .99 1.19 1.00 1.28 .82 1.41 1.01
KLA/ATP 1.42 1.63 1.24 1.61 .90 1.13 .93
Tcf3
KLA  ATP  ATP+KLA
 NM_001079822 transcription factor 3 (Tcf3), transcript variant 1, mRNA [NM_001079822] KLA 1.03 .98 1.01 .98 .98 1.03 1.01
ATP 1.00 1.02 1.00 1.06 1.10 1.07 .99
KLA/ATP 1.07 .99 .97 1.05 1.05 1.11 .96
Tcf7
KLA  ATP  ATP+KLA
 NM_009331 transcription factor 7, T-cell specific (Tcf7), mRNA [NM_009331] KLA 1.00 1.01 1.03 1.00 .98 1.01 1.07
ATP .99 .98 1.02 1.03 1.03 1.00 1.01
KLA/ATP 1.00 1.03 1.04 1.02 1.04 1.02 1.00
Tcf7l2
KLA  ATP  ATP+KLA
 NM_009333 transcription factor 7-like 2, T-cell specific, HMG-box (Tcf7l2), mRNA [NM_009333] KLA 1.01 1.12 1.11 1.31 1.06 1.34 1.29
ATP 1.04 1.05 .94 1.06 .90 .81 .96
KLA/ATP 1.08 1.11 1.05 1.18 1.04 1.02 1.42
Tead1
KLA  ATP  ATP+KLA
 NM_009346 TEA domain family member 1 (Tead1), mRNA [NM_009346] KLA 1.05 1.01 .99 .99 1.03 1.03 .97
ATP 1.03 .98 .97 .96 .93 1.00 1.03
KLA/ATP 1.05 .99 .98 .94 .95 .92 .97
Tead2
KLA  ATP  ATP+KLA
 NM_011565 TEA domain family member 2 (Tead2), mRNA [NM_011565] KLA .88 .84 .87 .88 .91 .94 .96
ATP .94 .96 .99 .90 .83 .90 .97
KLA/ATP .80 .82 .85 .85 .89 .84 .94
Tead3
KLA  ATP  ATP+KLA
 NM_011566 TEA domain family member 3 (Tead3), transcript variant 1, mRNA [NM_011566] KLA 1.14 1.12 1.13 1.17 1.18 1.03 .98
ATP .99 1.00 1.00 .97 .89 1.00 1.06
KLA/ATP 1.06 1.23 1.21 1.09 1.03 1.07 .99
Tead4
KLA  ATP  ATP+KLA
 NM_011567 TEA domain family member 4 (Tead4), transcript variant 1, mRNA [NM_011567] KLA 1.02 1.02 1.03 .96 1.03 1.00 1.07
ATP 1.01 .93 .99 1.07 .96 1.01 1.01
KLA/ATP 1.04 1.03 1.01 1.02 .99 1.00 .99
Tgfb1
KLA  ATP  ATP+KLA
 NM_011577 transforming growth factor, beta 1 (Tgfb1), mRNA [NM_011577] KLA .87 .89 .90 .70 .83 .77 1.12
ATP 1.20 1.41 .80 1.49 1.11 .93 .99
KLA/ATP 1.10 1.20 .53 1.05 .66 .85 .90
Tgfb2
KLA  ATP  ATP+KLA
 NM_009367 transforming growth factor, beta 2 (Tgfb2), mRNA [NM_009367] KLA 1.01 .91 .98 .98 .92 1.19 .96
ATP .99 1.03 1.00 1.02 .99 1.07 .93
KLA/ATP 1.02 .99 1.03 .98 1.04 1.06 .96
Tgfb3
KLA  ATP  ATP+KLA
 NM_009368 transforming growth factor, beta 3 (Tgfb3), mRNA [NM_009368] KLA .67 .64 .58 .56 .49 .52 .61
ATP .90 .92 1.33 1.08 .78 .65 .74
KLA/ATP .58 .60 .74 .61 .76 1.36 1.51
Tgfbr1
KLA  ATP  ATP+KLA
 NM_009370 transforming growth factor, beta receptor I (Tgfbr1), mRNA [NM_009370] KLA .73 .74 .59 .54 .52 .64 .84
ATP .99 1.12 .99 1.16 1.22 .84 .93
KLA/ATP .75 .78 .58 .64 .62 .59 .77
Tgfbr2
KLA  ATP  ATP+KLA
 AK090393 10 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:G630098D03 product:transforming growth factor, beta receptor II, full insert sequence. [AK090393] KLA .98 .89 1.00 .96 .94 1.00 .92
ATP .99 .99 .90 .94 .93 .96 1.02
KLA/ATP .92 .96 .98 .98 .98 .95 1.01
Tgfbr2
KLA  ATP  ATP+KLA
 NM_009371 transforming growth factor, beta receptor II (Tgfbr2), transcript variant 1, mRNA [NM_009371] KLA .55 .50 .58 .50 .52 .55 .44
ATP .98 .75 .50 .32 .41 .29 .50
KLA/ATP .59 .45 .32 .23 .31 .27 .25
Tgfbr2
KLA  ATP  ATP+KLA
 NM_029575 transforming growth factor, beta receptor II (Tgfbr2), transcript variant 2, mRNA [NM_029575] KLA .95 .93 .99 .95 .88 1.02 .82
ATP .87 .93 .84 .84 .74 .72 1.00
KLA/ATP .89 .85 .83 .85 .76 .80 .79
Trp53bp2
KLA  ATP  ATP+KLA
 NM_173378 transformation related protein 53 binding protein 2 (Trp53bp2), mRNA [NM_173378] KLA .80 .77 .91 1.00 1.03 1.18 1.18
ATP .98 .94 .70 .66 2.26 1.79 1.47
KLA/ATP .79 .78 .75 .67 1.86 2.04 1.98
Trp73
KLA  ATP  ATP+KLA
 BC069182 transformation related protein 73, mRNA (cDNA clone IMAGE:6826464) [BC069182] KLA .98 1.00 .95 .99 1.04 1.03 1.00
ATP 1.01 .97 1.01 1.06 1.04 1.01 1.08
KLA/ATP 1.02 .96 1.00 1.07 1.06 1.07 1.00
Trp73
KLA  ATP  ATP+KLA
 NM_011642 transformation related protein 73 (Trp73), mRNA [NM_011642] KLA 1.66 1.63 1.93 1.60 2.12 1.64 1.57
ATP 1.05 1.07 1.14 1.28 1.19 1.07 1.24
KLA/ATP 1.73 1.86 1.60 1.94 1.48 1.23 1.52
Wnt1
KLA  ATP  ATP+KLA
 NM_021279 wingless-related MMTV integration site 1 (Wnt1), mRNA [NM_021279] KLA 1.01 1.01 1.05 1.03 1.04 1.04 1.01
ATP .99 .99 1.01 .97 .96 1.01 1.00
KLA/ATP 1.01 1.04 1.06 1.02 1.00 .98 .98
Wnt10a
KLA  ATP  ATP+KLA
 NM_009518 wingless related MMTV integration site 10a (Wnt10a), mRNA [NM_009518] KLA 1.73 1.66 1.33 1.17 1.10 1.02 1.03
ATP 1.03 1.04 .93 1.02 1.04 1.07 1.06
KLA/ATP 1.83 1.67 1.53 1.21 1.10 1.12 1.09
Wnt10b
KLA  ATP  ATP+KLA
 NM_011718 wingless related MMTV integration site 10b (Wnt10b), mRNA [NM_011718] KLA 1.10 .98 1.13 1.01 .96 1.00 .96
ATP 1.02 1.02 .99 1.01 .96 1.02 1.01
KLA/ATP 1.01 1.18 .97 .97 1.03 1.04 .98
Wnt11
KLA  ATP  ATP+KLA
 NM_009519 wingless-related MMTV integration site 11 (Wnt11), mRNA [NM_009519] KLA .97 1.00 .97 1.03 1.16 1.08 1.11
ATP 1.03 1.06 1.08 1.23 1.13 1.03 1.08
KLA/ATP .95 1.00 .95 1.02 .97 1.04 1.04
Wnt16
KLA  ATP  ATP+KLA
 NM_053116 wingless-related MMTV integration site 16 (Wnt16), mRNA [NM_053116] KLA 1.00 1.02 .97 1.02 .96 1.02 1.05
ATP 1.01 1.00 .97 .98 .97 .95 1.02
KLA/ATP .96 1.01 .98 1.03 .99 1.00 .97
Wnt2
KLA  ATP  ATP+KLA
 NM_023653 wingless-related MMTV integration site 2 (Wnt2), mRNA [NM_023653] KLA 1.01 1.00 1.02 .96 1.06 1.03 .94
ATP .97 1.01 1.02 .98 1.00 1.05 1.01
KLA/ATP .97 .94 1.03 1.02 1.00 .99 1.05
Wnt2b
KLA  ATP  ATP+KLA
 NM_009520 wingless related MMTV integration site 2b (Wnt2b), mRNA [NM_009520] KLA 1.04 1.03 .99 1.01 .95 1.02 .99
ATP .95 1.00 .95 .99 .97 1.03 1.01
KLA/ATP 1.02 .99 1.01 1.06 .99 .99 1.02
Wnt3
KLA  ATP  ATP+KLA
 NM_009521 wingless-related MMTV integration site 3 (Wnt3), mRNA [NM_009521] KLA 1.04 1.02 1.04 1.02 1.00 .99 1.00
ATP 1.03 .98 1.04 1.04 .96 1.00 1.02
KLA/ATP 1.03 .99 .98 1.03 1.04 .94 1.03
Wnt3a
KLA  ATP  ATP+KLA
 NM_009522 wingless-related MMTV integration site 3A (Wnt3a), mRNA [NM_009522] KLA 1.01 1.00 1.06 1.02 .99 1.02 .99
ATP .96 .97 1.05 1.04 1.02 1.02 1.04
KLA/ATP 1.02 1.03 .96 1.01 .99 1.06 1.00
Wnt4
KLA  ATP  ATP+KLA
 NM_009523 wingless-related MMTV integration site 4 (Wnt4), mRNA [NM_009523] KLA 1.01 1.01 .97 1.06 1.12 1.02 .93
ATP 1.02 1.06 1.03 1.02 1.00 1.02 .98
KLA/ATP .94 1.01 1.06 1.05 .96 .96 1.00
Wnt5a
KLA  ATP  ATP+KLA
 NM_009524 wingless-related MMTV integration site 5A (Wnt5a), mRNA [NM_009524] KLA .98 1.06 1.01 .96 1.03 1.02 1.07
ATP 1.01 .96 1.06 1.11 1.02 .97 1.03
KLA/ATP 1.05 .96 .96 1.04 1.12 1.06 .96
Wnt5b
KLA  ATP  ATP+KLA
 NM_009525 wingless-related MMTV integration site 5B (Wnt5b), mRNA [NM_009525] KLA 1.04 1.04 1.19 1.11 1.10 1.11 1.05
ATP 1.04 1.01 .95 1.01 .99 1.04 1.05
KLA/ATP 1.05 1.06 1.11 1.07 1.04 1.08 1.05
Wnt6
KLA  ATP  ATP+KLA
 M89800 gb|Mouse Wnt-6 mRNA, complete cds. [M89800] KLA 1.92 1.97 1.93 2.04 2.01 2.62 5.22
ATP .96 .97 1.07 1.03 .76 .94 1.18
KLA/ATP 2.04 1.91 1.96 1.72 1.40 1.31 2.45
Wnt6
KLA  ATP  ATP+KLA
 NM_009526 wingless-related MMTV integration site 6 (Wnt6), mRNA [NM_009526] KLA 2.83 2.51 2.19 2.74 2.92 3.01 5.82
ATP 1.01 .87 1.07 .77 .59 1.11 1.06
KLA/ATP 2.31 2.49 2.69 1.79 1.63 1.26 2.64
Wnt7a
KLA  ATP  ATP+KLA
 NM_009527 wingless-related MMTV integration site 7A (Wnt7a), mRNA [NM_009527] KLA .96 .92 .91 .99 .96 .98 .97
ATP 1.05 .95 .98 .98 1.03 .98 1.11
KLA/ATP .92 .89 .88 .97 1.01 1.04 1.01
Wnt7b
KLA  ATP  ATP+KLA
 NM_009528 wingless-related MMTV integration site 7B (Wnt7b), mRNA [NM_009528] KLA 1.06 1.09 .99 1.09 1.06 1.19 1.26
ATP .99 .98 1.02 1.08 1.02 1.11 1.54
KLA/ATP 1.02 1.01 .99 1.14 1.07 1.09 1.58
Wnt8a
KLA  ATP  ATP+KLA
 NM_009290 wingless-related MMTV integration site 8A (Wnt8a), mRNA [NM_009290] KLA .92 1.01 .99 1.00 1.06 1.01 1.04
ATP 1.00 1.01 1.01 1.04 1.00 1.06 1.05
KLA/ATP 1.07 1.05 .99 1.08 1.07 1.09 1.07
Wnt8b
KLA  ATP  ATP+KLA
 NM_011720 wingless related MMTV integration site 8b (Wnt8b), mRNA [NM_011720] KLA 1.00 1.00 .94 1.03 .98 .98 .97
ATP .99 1.01 1.01 1.01 1.05 1.04 1.03
KLA/ATP .98 1.03 1.00 1.01 .99 1.02 1.02
Wnt9a
KLA  ATP  ATP+KLA
 NM_139298 wingless-type MMTV integration site 9A (Wnt9a), mRNA [NM_139298] KLA .93 .95 .95 1.01 .96 .97 1.01
ATP 1.01 .98 1.01 1.08 1.43 1.02 1.44
KLA/ATP .94 .96 1.03 1.15 1.43 1.15 1.21
Wnt9b
KLA  ATP  ATP+KLA
 NM_011719 wingless-type MMTV integration site 9B (Wnt9b), mRNA [NM_011719] KLA .97 1.00 .94 1.00 .99 .97 1.02
ATP .96 1.02 1.05 .99 .92 1.11 1.08
KLA/ATP .97 .96 .99 .93 .96 1.03 .99
Wtip
KLA  ATP  ATP+KLA
 NM_207212 WT1-interacting protein (Wtip), mRNA [NM_207212] KLA .64 .60 .55 .52 .42 .38 .30
ATP .87 .86 1.00 .88 .70 .65 .39
KLA/ATP .55 .57 .60 .53 .54 .45 .23
Wwc1
KLA  ATP  ATP+KLA
 AK220259 mRNA for mKIAA0869 protein [AK220259] KLA .65 .66 .54 .59 .57 .86 1.02
ATP .84 .89 1.04 2.09 5.02 3.37 11.04
KLA/ATP .61 .66 .69 1.02 3.32 3.34 7.49
Wwtr1
KLA  ATP  ATP+KLA
 NM_133784 WW domain containing transcription regulator 1 (Wwtr1), mRNA [NM_133784] KLA .96 1.01 .98 1.01 .97 .99 1.03
ATP 1.02 .98 .98 1.06 1.02 .99 .99
KLA/ATP 1.06 1.00 1.00 1.00 .98 .97 .98
Yap1
KLA  ATP  ATP+KLA
 NM_009534 yes-associated protein 1 (Yap1), mRNA [NM_009534] KLA .98 1.02 .97 .95 1.07 1.04 1.01
ATP 1.03 1.02 .95 .94 .97 .99 1.03
KLA/ATP 1.06 1.00 .99 1.02 .88 .92 1.00
Ywhab
KLA  ATP  ATP+KLA
 NM_018753 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (Ywhab), mRNA [NM_018753] KLA 1.03 1.15 1.18 1.10 1.20 1.20 1.23
ATP 1.02 1.08 .84 1.06 1.08 1.24 1.24
KLA/ATP 1.15 1.18 .82 1.17 .91 1.24 1.58
Ywhae
KLA  ATP  ATP+KLA
 NM_009536 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (Ywhae), mRNA [NM_009536] KLA 1.32 1.35 1.43 1.40 1.46 1.45 1.19
ATP 1.09 1.30 1.21 1.51 1.16 .97 1.01
KLA/ATP 1.45 1.50 1.33 1.85 1.25 1.16 1.08
Ywhag
KLA  ATP  ATP+KLA
 NM_018871 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (Ywhag), mRNA [NM_018871] KLA .87 .96 .92 .89 1.14 1.30 1.77
ATP 1.08 1.22 .86 .83 .91 1.46 1.09
KLA/ATP 1.05 1.04 .61 .72 .76 1.44 1.52
Ywhah
KLA  ATP  ATP+KLA
 NM_011738 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide (Ywhah), mRNA [NM_011738] KLA .55 .54 .49 .44 .38 .58 .70
ATP .99 .93 1.14 .81 .62 .53 1.07
KLA/ATP .54 .52 .54 .35 .37 .35 .68
Ywhaq
KLA  ATP  ATP+KLA
 AK037746 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130046D12 product:unclassifiable, full insert sequence [AK037746] KLA .97 .93 .94 .95 .97 .96 .95
ATP 1.09 1.07 1.44 1.49 1.04 1.01 .96
KLA/ATP 1.04 .96 1.11 1.36 1.01 1.03 .87
Ywhaq
KLA  ATP  ATP+KLA
 NM_011739 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide (Ywhaq), mRNA [NM_011739] KLA .93 .98 .96 .99 .92 .76 .88
ATP 1.07 1.08 1.01 1.35 1.37 1.28 .70
KLA/ATP .97 1.04 .94 1.17 1.09 1.18 .77
Ywhaz
KLA  ATP  ATP+KLA
 AK050511 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820005J08 product:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, full insert sequence. [AK050511] KLA .99 .96 .97 .96 1.00 .95 .96
ATP .99 1.00 .98 1.01 1.04 .94 1.01
KLA/ATP .99 .97 1.00 .98 .88 .97 1.01
Ywhaz
KLA  ATP  ATP+KLA
 NM_011740 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), mRNA [NM_011740] KLA 1.79 1.86 1.98 2.10 2.11 2.10 1.30
ATP 1.00 1.21 .95 1.37 1.21 1.42 1.08
KLA/ATP 1.73 1.92 1.58 2.28 1.68 1.76 1.47